The purpose of this study is to look at combinations of medicines given after a stem cell transplant and see how well the combinations work to prevent graft versus host disease and infection.
Thank you for your interest, but this study will start enrolling soon.
North Carolina (Statewide)
Katarzyna Jamieson
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Other Cancers, Leukemia, Lymphoma)
Transplant
25-1453
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
